The relationship between plasma vascular endothelial growth factor and plasma insulin like Growth factor-i levels on diabetic nephropathy in Patients with type 2 diabetes

Plasma Vascular endothelial growth factors (p VEGFs) as well as plasma insulin like growth factors- I (pIGFs- I) has been implicated in the pathogenesis of diabetes mellitus. This study was performed to determine whether alternations of p VEGFs and pIGFs are related to diabetic nephropathy in type 2 diabetic patients.Patients & Methods:We examined the association of pVEGFs and pIGFs concentrations with fasting glucose levels, glycosylated hemoglobin (HbA1c %), urinary measured renal parameters i.e. creatinine clearance and albuminuria in 75 patients with type 2 diabetes and 25 healthy controls. Study subjects were divided into four groups using urinary albumin-to-creatinine ratio (ACR). Results:We confirmed that (i) both pVEGFs and pIGFs showed remarkable increase in all diabetic groups with worsen A/Cr ratio, as compared with controls. (ii) p VEGFs and pIGFs were increased in diabetic patients as long as glycemic control was not achieved. (iii) Vascular endothelial growth factor in plasma as well as plasma insulin like growth factors elevations were also revealed statistically. (iv) Direct positive correlation between pVEGFs and pIGFs-I with glycemic control index, albuminuria were noticed. Conclusion:The release of both p VEGFs as well as pIGFs was increased during the earlier stage of diabetic nephropathy and were significantly correlated with urinary albumin excretion. This suggested that pVEGFs could be used as an early sensitive marker for the diagnosis before the stage of microalbuminuria. and for predicting disease progression to start therapy very early.